Dr. Darrow is an Assistant Professor at Harvard Medical School and a faculty member in the Division of Pharmacoepidemiology and Pharmacoeconomics in the Department of Medicine at Brigham and Women’s Hospital. He holds a research doctorate in pharmaceutical policy from Harvard, where he also completed an LL.M. program (intellectual property), and holds degrees in biological sciences (genetics), law, and business from Cornell, Duke, and Boston College, respectively. After admission to the California bar, Dr. Darrow worked on emerging company issues at Cooley LLP (Palo Alto, CA) and, after admission to the patent bar, on pharmaceutical litigation matters at Wiley LLP (Washington, DC). He has served as Senior Law Clerk to the Honorable Evan J. Wallach of the U.S. Court of Appeals for the Federal Circuit, taught summer school for the World Intellectual Property Organization (WIPO) / University of Geneva, supported the work of the innovation divisions of the World Health Organization and World Trade Organization, and lectured and published widely on FDA regulation, pharmaceuticals, innovation, competition, and intellectual property. He is a Faculty Affiliate of Harvard Law School’s Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics, and an author of several textbooks, including Cyberlaw: Cases and Materials (Cengage 2012 and Aspen 2015), The Legal and Ethical Environment of Business (Wolters Kluwer 2014 and 2018), and Business Law for Entrepreneurs (forthcoming 2021).